Parallel Advisors’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.59K | Buy |
700
+283
| +68% | +$3.47K | ﹤0.01% | 2511 |
|
|
2025
Q1 | $9.17K | Hold |
417
| – | – | ﹤0.01% | 2456 |
|
|
2024
Q4 | $9.46K | Buy |
417
+363
| +672% | +$8.23K | ﹤0.01% | 2405 |
|
|
2024
Q3 | $981 | Sell |
54
-281
| -84% | -$5.11K | ﹤0.01% | 3025 |
|
|
2024
Q2 | $9.76K | Buy |
335
+166
| +98% | +$4.84K | ﹤0.01% | 2314 |
|
|
2024
Q1 | $5.99K | Sell |
169
-363
| -68% | -$12.9K | ﹤0.01% | 2476 |
|
|
2023
Q4 | $23.2K | Buy |
532
+177
| +50% | +$7.71K | ﹤0.01% | 1842 |
|
|
2023
Q3 | $13.6K | Sell |
355
-36
| -9% | -$1.38K | ﹤0.01% | 2055 |
|
|
2023
Q2 | $16.1K | Sell |
391
-316
| -45% | -$13K | ﹤0.01% | 1950 |
|
|
2023
Q1 | $40.6K | Buy |
707
+259
| +58% | +$14.9K | ﹤0.01% | 1482 |
|
|
2022
Q4 | $25.1K | Sell |
448
-36
| -7% | -$2.02K | ﹤0.01% | 1610 |
|
|
2022
Q3 | $21K | Buy |
484
+84
| +21% | +$3.65K | ﹤0.01% | 1648 |
|
|
2022
Q2 | $22K | Buy |
400
+348
| +669% | +$19.1K | ﹤0.01% | 1613 |
|
|
2022
Q1 | $3K | Sell |
52
-16
| -24% | -$923 | ﹤0.01% | 2455 |
|
|
2021
Q4 | $5K | Buy |
68
+9
| +15% | +$662 | ﹤0.01% | 2384 |
|
|
2021
Q3 | $4K | Buy |
59
+18
| +44% | +$1.22K | ﹤0.01% | 2436 |
|
|
2021
Q2 | $3K | Hold |
41
| – | – | ﹤0.01% | 2436 |
|
|
2021
Q1 | $3K | Hold |
41
| – | – | ﹤0.01% | 2353 |
|
|
2020
Q4 | $3K | Hold |
41
| – | – | ﹤0.01% | 2184 |
|
|
2020
Q3 | $2K | Sell |
41
-7
| -15% | -$341 | ﹤0.01% | 2286 |
|
|
2020
Q2 | $2K | Buy |
48
+12
| +33% | +$500 | ﹤0.01% | 2189 |
|
|
2020
Q1 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 2272 |
|
|
2017
Q1 | – | Sell |
-180
| Closed | -$8K | – | 2029 |
|
|
2016
Q4 | $8K | Buy |
+180
| New | +$8K | ﹤0.01% | 1192 |
|